Cholesterol Conjugates of Small Interfering RNA: Linkers and Patterns of Modification

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Cholesterol siRNA conjugates enable cellular delivery of small interfering RNA (siRNA) without transfection agents.
• Investigating modifications and linker lengths is crucial for optimizing siRNA conjugate efficacy.

Purpose of the Study:

• To compare the efficacy and duration of gene silencing by cholesterol conjugates of selectively and totally modified siRNAs.
• To explore the impact of linker length on siRNA conjugate activity.
• To assess the effect of siRNA strand modifications on silencing performance.

Main Methods:

• Synthesis and evaluation of cholesterol-conjugated siRNAs with varying modifications and linker lengths.
• Comparison of silencing activity in both transfection-mediated and carrier-free delivery modes.
• Assessment of MDR1 gene expression suppression in a mouse xenograft model.

Main Results:

• 3'-cholesterol conjugates showed varying activity based on linker length in carrier-free mode, with longer linkers being more effective.
• 5'-cholesterol conjugates exhibited superior activity compared to 3'-conjugates.
• Fully modified siRNAs (both strands) significantly enhanced silencing efficacy and duration in both delivery methods.
• Significant 78% suppression of MDR1 gene expression was observed in tumors using fully modified siRNA cholesterol conjugates.

Conclusions:

• Cholesterol modification strategies, particularly full siRNA strand modification, significantly enhance gene silencing.
• Optimized siRNA cholesterol conjugates hold promise for improved therapeutic applications, including combination chemotherapy.